Showing results (2041-2050 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|April 6, 2022
Treatment Patterns Among Patients with Bipolar Disorder in the United States: A Retrospective Claims Database AnalysisRakesh Jain, Amanda M Kong, Patrick Gillard, et al.
Advances in Therapy|April 8, 2022
Pembrolizumab Plus Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A Cost-Effectiveness AnalysisYouwen Zhu, Kun Liu, Dong Ding, et al.
Advances in Therapy|May 3, 2022
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy SubgroupAnnabelle A Okada, Kanji Takahashi, Masahito Ohji, et al.
Advances in Therapy|April 22, 2022
Recommendations from a Working Group on Obesity Care Competencies for Healthcare Education in the UK: A Report by the Steering CommitteeMatthew S Capehorn, Nigel Hinchliffe, Deborah Cook, et al.
Advances in Therapy|May 16, 2023
Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United StatesShujing Zhang, Arielle G Bensimon, Ruifeng Xu, et al.
Advances in Therapy|May 18, 2023
Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor StudiesKyle Berman, Simon Moss, Barry Holden-Theunissen, et al.
Advances in Therapy|May 10, 2023
An Economic Analysis of Transjugular Intrahepatic Portosystemic Covered Stent Shunt for Variceal Bleeding and Refractory Ascites in a Spanish SettingRafael Bañares, Agustín Albillos, Mitesh Nakum, et al.
Advances in Therapy|August 21, 2020
Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use ConditionsDongkuk Park, Jihyun Kim, Jihoon Yun, et al.
Advances in Therapy|April 7, 2023
A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of AsthmaJohn Haughney, Tonya Winders, Steve Holmes, et al.
Advances in Therapy|April 12, 2023
Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?Jennifer Catherine Louise Camaradou, Henry David Jeffry Hogg
Pageof 457